We are proud to count many of the world's leading immunologists and tumor immunologists among our community of scientific leaders. These include Nobel laureates and members of the National Academy of Sciences, as well as clinical oncologists with expertise in cancer immunotherapy, and industry leaders versed in the challenges of drug development.
Together, these experts ensure that our programs continue to achieve the most impact possible and that the Cancer Research Institute remains at the cutting-edge of the science of tumor immunology and cancer immunotherapy.
A distinguished body of the world's leading expert immunologists who voluntarily guide the development of the Institute’s cancer immunology research programs.
A group of experienced industry leaders who represent the Cancer Immunotherapy Consortium (CIC).
Experts in clinical trial strategy, planning, and management, nonprofit investment fund management, program administration, and communications.